NCT03212534

Brief Summary

Through the mapping of retrospective patient data into a discrete multidimensional space, a novel algorithm for homeostatic analysis, was built to make outcome predictions. In this prospective study, the ability of the algorithm to predict patient mortality and influence clinical outcomes, will be investigated.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2017

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 11, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

September 24, 2021

Status Verified

September 1, 2021

Enrollment Period

3 months

First QC Date

July 6, 2017

Last Update Submit

September 20, 2021

Conditions

Keywords

Dascenapatient mortalitymachine learningalgorithmdiagnostic

Outcome Measures

Primary Outcomes (1)

  • In-hospital mortality

    Through study completion, an average of 30 days

Secondary Outcomes (1)

  • Hospital length of stay

    Through study completion, an average of 30 days

Other Outcomes (2)

  • Hospital readmission

    Through study completion, an average of 30 days

  • ICU length of stay

    Through study completion, an average of 30 days

Study Arms (2)

Prediction Algorithm

EXPERIMENTAL
Other: Patient mortality prediction

Control

NO INTERVENTION

Interventions

Healthcare provider is notified of patient mortality prediction.

Prediction Algorithm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All adult patients admitted to the participating units will be eligible.

You may not qualify if:

  • All patients younger than 18 years of age will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSF Moffit-Long Hospital

San Francisco, California, 94143, United States

Location

Related Publications (4)

  • Desautels T, Calvert J, Hoffman J, Mao Q, Jay M, Fletcher G, Barton C, Chettipally U, Kerem Y, Das R. Using Transfer Learning for Improved Mortality Prediction in a Data-Scarce Hospital Setting. Biomed Inform Insights. 2017 Jun 12;9:1178222617712994. doi: 10.1177/1178222617712994. eCollection 2017.

    PMID: 28638239BACKGROUND
  • Calvert J, Mao Q, Rogers AJ, Barton C, Jay M, Desautels T, Mohamadlou H, Jan J, Das R. A computational approach to mortality prediction of alcohol use disorder inpatients. Comput Biol Med. 2016 Aug 1;75:74-9. doi: 10.1016/j.compbiomed.2016.05.015. Epub 2016 May 24.

    PMID: 27253619BACKGROUND
  • Calvert JS, Price DA, Barton CW, Chettipally UK, Das R. Discharge recommendation based on a novel technique of homeostatic analysis. J Am Med Inform Assoc. 2017 Jan;24(1):24-29. doi: 10.1093/jamia/ocw014. Epub 2016 Mar 28.

    PMID: 27026611BACKGROUND
  • Calvert J, Mao Q, Hoffman JL, Jay M, Desautels T, Mohamadlou H, Chettipally U, Das R. Using electronic health record collected clinical variables to predict medical intensive care unit mortality. Ann Med Surg (Lond). 2016 Sep 6;11:52-57. doi: 10.1016/j.amsu.2016.09.002. eCollection 2016 Nov.

    PMID: 27699003BACKGROUND

MeSH Terms

Conditions

Heart FailureDeathDisease

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • David Shimabukuro

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2017

First Posted

July 11, 2017

Study Start

July 1, 2017

Primary Completion

October 1, 2017

Study Completion

October 1, 2017

Last Updated

September 24, 2021

Record last verified: 2021-09

Locations